| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1041210923 |
| P356 | DOI | 10.1186/1742-2094-7-58 |
| P8608 | Fatcat ID | release_onhd7noasnhslglyuuvlquxoui |
| P953 | full work available at URL | https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/1742-2094-7-58 |
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20920308/pdf/?tool=EBI | ||
| https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20920308/?tool=EBI | ||
| https://europepmc.org/articles/PMC2958902 | ||
| https://europepmc.org/articles/PMC2958902?pdf=render | ||
| P932 | PMC publication ID | 2958902 |
| P698 | PubMed publication ID | 20920308 |
| P5875 | ResearchGate publication ID | 47335523 |
| P2093 | author name string | Ahmad Ghanizadeh | |
| P2860 | cites work | Neurotensin modulation of acetylcholine, GABA, and aspartate release from rat prefrontal cortex studied in vivo with microdialysis | Q34812081 |
| Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment. | Q36900640 | ||
| GABA(A) receptor downregulation in brains of subjects with autism | Q37229115 | ||
| Neurotensin enhances endogenous extracellular glutamate levels in primary cultures of rat cortical neurons: involvement of neurotensin receptor in NMDA induced excitotoxicity | Q44803986 | ||
| Neurotensin enhances GABAergic activity in rat hippocampus CA1 region by modulating L-type calcium channels | Q46704914 | ||
| Non-invasive evaluation of the GABAergic/glutamatergic system in autistic patients observed by MEGA-editing proton MR spectroscopy using a clinical 3 tesla instrument | Q48116100 | ||
| Atypical neuroleptic-like behavioral effects of neurotensin | Q48385983 | ||
| Memantine as adjunctive therapy in children diagnosed with autistic spectrum disorders: an observation of initial clinical response and maintenance tolerability | Q28240095 | ||
| Neurotensin receptors as modulators of glutamatergic transmission | Q28261782 | ||
| Neurotensin inhibition of GABAergic transmission via mGluR-induced endocannabinoid signalling in rat periaqueductal grey | Q28580090 | ||
| Neurotensin activates GABAergic interneurons in the prefrontal cortex | Q28581544 | ||
| Neuroprotection of interleukin-6 against NMDA-induced apoptosis and its signal-transduction mechanisms | Q33662170 | ||
| Neurotensin is increased in serum of young children with autistic disorder | Q34114124 | ||
| Use of nonpeptide antagonists to explore the physiological roles of neurotensin. Focus on brain neurotensin/dopamine interactions. | Q34426946 | ||
| Increased serum levels of glutamate in adult patients with autism. | Q34550517 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | autism | Q38404 |
| P304 | page(s) | 58 | |
| P577 | publication date | 2010-10-01 | |
| P1433 | published in | Journal of Neuroinflammation | Q15716679 |
| P1476 | title | Targeting neurotensin as a potential novel approach for the treatment of autism | |
| P478 | volume | 7 |
| Q26746354 | Atopic diseases and inflammation of the brain in the pathogenesis of autism spectrum disorders |
| Q38376352 | Beta-lactam antibiotics as a possible novel therapy for managing epilepsy and autism, a case report and review of literature |
| Q37537023 | Elevated serum neurotensin and CRH levels in children with autistic spectrum disorders and tail-chasing Bull Terriers with a phenotype similar to autism. |
| Q30426586 | Elucidating the role of neurotensin in the pathophysiology and management of major mental disorders. |
| Q38086129 | Exploring the multifactorial nature of autism through computational systems biology: calcium and the Rho GTPase RAC1 under the spotlight |
| Q36766675 | Focal brain inflammation and autism |
| Q21195853 | Hyperbaric oxygen therapy for treatment of children with autism: a systematic review of randomized trials |
| Q37965051 | Malondialdehyde, Bcl-2, superoxide dismutase and glutathione peroxidase may mediate the association of sonic hedgehog protein and oxidative stress in autism |
| Q50313076 | May lovastatin target both autism and epilepsy? A novel hypothesized treatment |
| Q41353618 | N-acetylcysteine for treatment of autism, a case report |
| Q35800334 | Neuro-inflammation, blood-brain barrier, seizures and autism |
| Q42489739 | Neurotensin regulates cortical glutamate transmission by modulating N-methyl-D-aspartate receptor functional activity: an in vivo microdialysis study |
| Q50310961 | Nuclear factor kappa B may increase insight into the management of neuroinflammation and excitotoxicity in autism |
| Q42529006 | Physical exercise and intermittent administration of lactulose may improve autism symptoms through hydrogen production |
| Q91623537 | Pioglitazone abolishes cognition impairments as well as BDNF and neurotensin disturbances in a rat model of autism |
| Q41846883 | Targeting Mitochondria by Olesoxime or Complement 1q Binding Protein as a Novel Management for Autism: A Hypothesis |
| Q50313274 | c-Kit+ cells transplantation as a new treatment for autism, a novel hypothesis with important research and clinical implication |
Search more.